Oculis Holding AG OCS
NASDAQ OCS
$12.17 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Oculis Holding AG (OCS) Receivables - Other (2023 - 2025)

Oculis Holding AG (OCS) posted quarterly Receivables - Other of $13.3 million for Q4 2025, up 305.86% year-over-year from $3.3 million in Q4 2024, and up 305.86% quarter-over-quarter from $3.3 million in Q4 2024.

Analysis

Oculis Holding AG (OCS) Receivables - Other (2023 - 2025) Analysis & Trends

Oculis Holding AG's Receivables - Other history runs 5 years deep, the most recent figure standing at $13.3 million for Q4 2025.

  • In Q4 2025, Receivables - Other rose 305.86% year-over-year to $13.3 million; the TTM figure through Dec 2025 stood at $13.3 million (up 305.86% YoY), while the FY2025 annual figure was $12.9 million, up 292.91% from the prior year.
  • Receivables - Other for Q4 2025 stood at $13.3 million, up from $3.3 million in the prior quarter.
  • The five-year high for Receivables - Other was $13.3 million in Q4 2025, with the low at $1038.0 in Q4 2022.
  • The 5-year median for Receivables - Other is $2.4 million (2023), against an average of $3.8 million.
  • The sharpest annual moves came in 2022 and 2023: Receivables - Other plunged 96.7% in 2022, then surged 232859.95% in 2023.
  • Oculis Holding AG's Receivables - Other stood at $31450.6 in 2021, then slumped by 96.7% to $1038.0 in 2022, then soared by 232859.95% to $2.4 million in 2023, then jumped by 35.86% to $3.3 million in 2024, then jumped by 305.86% to $13.3 million in 2025.
  • Business Quant data shows OCS's Receivables - Other at $13.3 million in Q4 2025, $3.3 million in Q4 2024, and $2.4 million in Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Oculis Holding AG 634.75 Mn 345.87 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 13.33 Mn
Dec 31, 2024 3.29 Mn
Dec 31, 2023 2.42 Mn